Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 2Other neoplasm 2Lymphoid 1

Conditions

Multiple Myeloma 5Precancerous Conditions 2Neoplasms, Plasma Cell 2Monoclonal Gammopathy of Undetermined Significance 2Waldenstrom Macroglobulinemia 1Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Myelodysplastic Syndromes 1Lymphoma 1Immunoglobulin Light-chain Amyloidosis 1

Interventions

Peripheral Blood Stem Cell Transplantation 7Cyclophosphamide 7fludarabine phosphate 6Whole-Body Irradiation 5Epoetin Alfa 5Tacrolimus 4Mycophenolic Acid 4Cyclosporine 4Busulfan 4Antilymphocyte Serum 4Methotrexate 3Etoposide 3Darbepoetin alfa 3Sirolimus 2Morphine 2Methylprednisolone 2Melphalan 2Interferon-alpha 2Filgrastim 2Cytogenetic Analysis 2Carboplatin 2sargramostim 1pyroxamide 1ferrous sulfate 1ferric gluconate 1alethine 1aldesleukin 1Topotecan 1Therapeutics 1Tetradecanoylphorbol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Precancerous Conditions × Cytogenetic Analysis × Plasma cell × Clear all
NCT00900263 2016-10-07

S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma

SWOG Cancer Research Network

Completed
375 enrolled
Other neoplasmPlasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Precancerous Conditions

NCT00898066 2015-03-06

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

SWOG Cancer Research Network

Completed
37 enrolled
LymphoidOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Lymphoma, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Precancerous Conditions, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡